Saponins, the glycosides of steroids or triterpenes, are widely distributed in plants and animals. 1) They exist in relatively high quantities in many significant food and beverage plants, including oats, peanuts, soybeans, lentils, mung beans, garlic, onions, spinach, asparagus, jujube, quillaja and tea. Saponins also are generally found as active constituents in many well known oriental herbal medicines such as ginseng, notoginseng, licorice, horse chestnut, red clover, senegae, and primula.
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2) Many previous studies reveal that saponins show various physiological and pharmacological activities, such as anti-cancer, anti-inflammatory, cardiovascular, and cytotoxic activities. 3, 4) The oligosaccharides integrated into the saponins have a very important role in their bioactivity and thus the interest in this sugar unit is rapidly increasing. For example, when the ether-linked tetrasaccharide was removed from julibrosides, its cytotoxicity dramatically decreased. We recently reported Pulsatilla saponin D, hederagenin 3-O-a-L-rhamnopyranosyl-(1→2)-[b-D-glucopyranosyl-(1→4)]-a-L-arabinopyranoside, as an anticancer component. 5) In addition, a total 17 triterpenoid saponins including six new saponins were isolated from Pullsatilla koreana N. root and the structure-activity relationships of antitumoral saponins was published. 6, 7) Among them, Pullsatilla saponin D (1, inhibition ratio (IR): 66.9% against LLC lung carcinoma xengraft model at 6.0 mg/kg/d i.p., ED 50 3.04- 50 1.57-8.36 mM) exhibited highly potent anticancer activity. Pulsatilla saponin D shows five times more active in anticancer test than its aglycone (ED 50 ; Ͼ50 mM). 8, 9) This indicated that the presence of a sugar moiety, O-a-Lrhamnopyranosyl-(1→2)-[b -D-glucopyranosyl-(1→4)]-a -Larabinopyranoside, at C-3 position enhances the activity. It has been postulated that the linked trisaccharide improves the bioavailability in tumor tissue in vivo. Therefore, this moiety could be utilized as a promoiety for the increment of the activity of other antitumoral compounds and their solubility in water as shown in Fig. 1 . Indeed, glucose has been integrated into anticancer agents as a conjugate for the improvement of their activity since cancer cells have increased rate of glucose metabolism compared with healthy cells and over-expression of GLUT-1. 10, 11) This approach has been also applied to pep-tide drugs 12) and cytotoxic agents 13, 14) for improvement of delivery into the central nervous system (CNS). Although there are some studies on natural oligosaccharide (i.e., Digitoxin), 15) these attempts have been mainly restricted to conjugation with a monosaccharide. 16) For the concrete investigation of pharmacological function as a promoiety of a-L-
mM) and oleanolic acid 3-O-a-L-rhamnopyranosyl-(1→2)-[b -D-glucopyranosyl-(1→4)]-a -L-arabinopyranoside (2, ED
]-a -Larabinopyranosyl moiety of 1, the simple and effective synthetic route of this sugar moiety is urgently needed. Accordingly, a synthetic method of trisaccharide moiety (3) was designed and the detail procedure is described in this paper.
Results and Discussion
Although numerous efforts have been devoted to the synthesis of diverse carbohydrate structures which is occurred in nature, it is still complicated in their synthesis. This can be attributed mainly to difficulties in synthesizing oligosaccharides, unlike proteins and nucleic acids, because (i) the molecules are typically branched rather than linear, (ii) the monosaccharide units can be connected by a-or b-linkages, and (iii) oligosaccharide synthesis requires multiple selective protection and deprotection steps. Although considerable progress has been made in the field over the past few decades, there is still no general route for synthesis of oligosaccharide and glycosylation chemistry is often not predictable. 17) However the method for the synthesis of oligosaccharides devised by Schmidt and his coworkers are frequently successful for forming mainly or exclusively a-or blinkage product. 18) Based on this strategy, we efficiently performed the synthesis of protected trisaccharide moiety of 1. Initially we selected 4-methoxybenzyl a-L-arabinopyranoside (4) as an effective starting point because the synthetic route shown in Chart 1 could be stereoselectively formed 1→4 linkage and the 4-methoxybenzyl (MPM) group at anomeric position of 4 can be removed under mild condition. The starting compound 4-methoxybenzyl a-L-arabinopyranoside (4) synthesized readily form L-arabinose in four steps with 40-50%. 19) Reaction of 4-methoxybenzyl a-L-arabinopyranoside (4) with 2,2-dimethoxypropane in N,N-dimethylformamide (DMF) containing p-toluenesulfonic acid (p-TsOH) at room temperature for 3 h, allylation of 2-OH with allyl bromide and NaH at 0°C for 1 h, and then removal of the acetonide in 70% aq. acetic acid (AcOH) gave compound 5 in overall 71% yield (three steps). The 4-methoxybenzyl 2-O-allyl-a-Larabinopyranoside (5) was reacted with dibutyltin oxide (Bu 2 SnO) in MeOH to give the corresponding 3,4-O-stannylidene derivative, which was subsequently treated with benzyl bromide (BnBr) in the presence of tetrabutylammonium (Bu 4 NBr) in toluene to afford 4-methoxybenzyl 2-Oallyl-3-O-benzyl-a-L-arabinopyranoside 6 in 68% yield. At first, coupling reaction of 6 with thioglucoside donor 7 20) using N-iodosuccinimide (NIS) and triflic acid (TfOH) as an iodonium ion was attempted. 21) But the desired disaccharide 9 was not produced. Therefore the other coupling condition using trichloroacetimidate donor 8 18, 22, 23) and trimethylsilyl trifluoromethanesulfonate (TMSOTf) as catalyst at Ϫ20°C in dry CH 2 Cl 2 was applied. The completed reaction mixture was purified by silica gel chromatography (3 : 1 cHx-EtOAc) to give the b-(1→4) linked disaccharide 9 (Glc J 1,2 values 7.6 Hz) as major product (83%) contaminated by a small amount of impurities (about 8%) in NMR spectra. For that reason, an additional purification step using preparative HPLC elution with 80% acetonitrile (flow rate: 1 ml/min, t R ϭ17.53 min) was performed to provide pure compound 9 (isolated yield: 71%). The a-anomer of 9 was not detected. This compound 9 was subsequently treated with palladium chloride (PdCl 2 ) 24) in CH 2 Cl 2 -MeOH to afford 2-O-deallylated disaccharide 10 in 42% yield. However, as shown in Chart 1, the final glycosylation reaction of 10 and trichloroacetimidate 11 25) catalyzed by TMSOTf was not accomplished under various conditions. It may be attributed to the instability of 4-methoxybenzyl group at anomeric position of the acceptor under acidic conditions. In recovering process of starting material, a by-product lost 4-methoxybenzyl group from 10 was obtained in 11% yield. Therefore, we needed the revised synthetic route with starting material of Larabinose having more stable and solid protecting group than 4-methoxybenzyl group at anomeric position. Therefore, the more stable and the less crowded allyl group directed equatorially in place of 4-methoxybenzyl group at anomeric position was selected as shown in Chart 2. The starting material compound 13 having an allyl group at 1-OH was readily prepared in 85% yield under the Paul's condition. 19 ) Treatment of allyl b-L-arabinopyranoside (13) with 2,2-dimetoxypropane in dry DMF containing p-TsOH at room temperature for 6 h gave the 3,4-isopropylidene derivative (14) , which was used without purification in the next step. Lewis acid-catalyzed assembly of 14 with the donor 2,3,4-tri-Obenzoyl-a-L-rhamnopyranosyl tirchloroacetimidate (11) by TMSOTf at a low temperature gave disaccharide 15 (63%) exclusively. The success of the reaction was evident from the down field shift in the (17) monoacetylated on the axial hydroxyl group of arabinose C-4, compound 16 was treated triethyl orthoacetate (CH 3 C(OEt) 3 ) and p-TsOH as acid catalyst in toluene and subsequently cleaved the intermediate cyclic ortho ester under acidic condition (80% aq. HOAc). As a result, compound 18 was attained in the good yield (71%) in two steps. The structure of 18 was unambiguously confirmed by 400 MHz 1 H-NMR spectroscopy with a singlet peak of acetyl at d 2.17. Benzoylation of 18 with benzoyl chloride in pyridine, and then selective 4-O-deacetylation with acetyl chlo- (20) in 68% yield in two steps. In the following step, coupling of appropriately protected compound 20 with 2,3,4,6-tetra-O-benzoyl-a-D-glucopyranosyl trichloroacetimidate 8 was successfully underwent to give the desired trisaccharide 3 (62%) containing a trace amount of impurities (Ͻ3%) in NMR spectra. The impurities were readily eliminated by recrystallization from 3 : 1 petroleum ether-MeOH (isolated yield of 3: 53%).
Although compound 3 is the protected derivative of
, its cytotoxicity was measured against three human cancer cell lines (A-549, SK-OV-3, and SK-MEL-2) for the possible prediction of cytotoxic effect of this sugar motif. As expected, this compound did not show any activity (ED 50 : Ͼ100 mM). This result might indicate that the trisaccharide moiety of Pulsatilla saponin D would only have the role of carrier moiety of prodrug. Therefore this trisaccharide 3 could be used as a nontoxic promoiety 26) for the enhancement of activity of anticancer drugs.
In conclusion, a highly efficient and concise synthesis of trisaccharide moiety 3 was developed through the regio-and steroselective glycosylations from arabinose in total 16% yield via route 2 in eight steps. To prepare the full protected and practical trisaccharide moiety allyl-2,3,
closely related with biological activity in Pulsatilla saponins, the protection of anomeric -OH of L-arabinose with equatorially oriented allyl group unlike with the axial 4-methoxybenzyl protecting group well promoted glycosyl bond formation between a-L-rhamnopyranosyl trichloroacetimidate and 2-OH of arabinose. The (1→4) coupling reaction with b-D-glucopyranose in route 2 gave nearly pure product 3 and possible benzoyl group transfer products or ortho esters have not been detected. Currently, studies on integrating the synthesized trisaccharide template 3 which has a possibility as a targeting soluble carrier of diverse drugs with linkable anticancer agents are underway, and the result will be reported in due course. On the other hand, this result provides a basis of the total synthesis of Pulsatilla saponin D possessing a potent anticancer activity.
Experimental
All reagents and solvents were dried prior to use according to standard methods (Perrin, D. D.; Amarego, W. L.; Perrin, D. R., Purification of laboratory chemicals; Pergamon: London, 1996). Commercial reagents were used without further purification unless otherwise stated. Reactions were followed by thin-layer chromatography (TLC) on Merck glass silica gel (Kieselgel 60 F 254 ) plates that were visualized under a UV lamp. Chromatographic separations were performed on silica gel columns by flash (Kieselgel 40, 0.040-0.063 mm; Merck) or gravity column (Kieselgel 60, 0.063-0.200 mm; Merck). HPLC was performed using a Shimadzu liquid chromatograph model Class-vp version 6.12, equipped with a SPD-10A UV-vis detector (Shimadzu). The preparative HPLC separation of compound 9 was performed using a Spherisorb ® S5 ODS2 column (250 mmϫ10 mm, RP-C 18 , 5 mm, Waters, Milford, MA, U.S.A.), and all solvents for HPLC were filtered through a 0.45 mm membrane filter (Waters). Melting points were measured on an Electrothermal melting point apparatus. IR spectra were obtained on KBr disks using a JASCO Report 100 spectrophotometer. NMR spectra were recorded on Bruker MSL-300 or -500 instrument operating at 400 MHz, the chemical shift (d) is reported in parts per million downfield from tetramethylsilane (TMS) and from solvent references. Electron impact (EI) mass spectra were obtained on a HP-5988A mass spectrometer, and HR-FAB-MS were recorded on a JMS-HX110/110A spectrometer. 
4-Methoxybenzyl 2,3,4,6-Tetra-O-benzoyl-b b-D-glucopyranosyl-(1→ →4)-

2-O-allyl-3-O-benzyl-a a-L-arabinopyranoside (9)
A suspension of compound 6 (240 mg, 0.60 mmol), trichloroacetimidate 8 13, 17) (533 mg, 0.72 mmol), and 4 Å molecular sieves (500 mg) in dry CH 2 Cl 2 (20 ml) was stirred for 1 h at room temperature under N 2 atmosphere. The mixture was cooled to Ϫ20°C, then was added TMSOTf (0.1 eq, 13 ml) as catalyst via syringe. After stirring for 2 h at same temperature, the mixture was neutralized with triethylamine (Et 3 N), filtered with Celite, and then concentrated in vacuo. The residue was purified on a Si gel column chromatography using the 3 : 1 cHx-EtOAc as eluent to give colorless solid 9 (483 mg, 82.7%) contaminated with a little impurity. An additional purification step using preparative HPLC elution with 80% MeCN (flow rate: 1 ml/min, t R ϭ17.53 min) was performed to give full-purified 9 (405 mg, isolated yield: 71.4% (10 ml), and the reaction mixture was stirred for 48 h at room temperature. After starting material was completely disappeared, the mixture was filtered through Celite, evaporated, and then the residue was purified by column chromatography using 
Allyl-2,3,4-tri-O-benzoyl-a a -L-rhamnopyranosyl-(1→ →2)-3,4-O-iso-
propylidene-b b-L-arabinopyranoside (15) A suspension of 13 (300 mg, 1.58 mmol), 12) 2,2-dimethoxypropane (388 ml, 3.16 mmol), and p-TsOH (30 mg, 0.16 mmol) in dry DMF (20 ml) was stirred for 6 h at room temperature. The reaction mixture was stopped by the addition of Et 3 N (100 ml) and then the mixture was diluted with diethyl ether (Et 2 O, 100 ml) and washed with H 2 O (100 ml). The aqueous layer was extracted with Et 2 O (100 mlϫ3). The organic layers was combined, washed with satd. NaHCO 3 (400 ml) and satd. NaCl (400 ml), and dried with Na 2 SO 4 . Solvents were evaporated and the residue (allyl-(1→2)-3,4-O-isopropylidene-b-L-arabinopyranoside, 14) was used without further purification in the following step.
A solution of this isopropylidene 14 (278 mg, 1.21 mmol), trichloroacetimidate 11 (977 mg, 1.57 mmol), 18) and 4 Å molecular sieves (500 mg) in dry CH 2 Cl 2 (20 ml) was treated with TMSOTf (0.1 eq) in the same manner as that described for compound 9. After stirring for 2 h at this temperature, the mixture was neutralized with triethylamine (Et 3 N), filtered with Celite, and then concentrated in vacuo. The residue was purified by a Si gel column chromatography using the 5. .58 mmol) in CH 2 Cl 2 -MeOH (1 : 2, 30 ml) and the mixture was stirred at room temperature for 6 h when the deprotection had completed on TLC (cHx-EtOAcϭ3 : 1), and then Et 3 N (0.1 ml) was added and the mixture was concentrated and purified by a Si gel column chromatography using the Allyl-2,3,4-tri-O-benzoyl-a a- solution of 16 (346 mg, 0.53 mmol) , CH 3 C(OEt) 3 (483 ml, 2.65 mmol) and p-TsOH (50 mg, 0.265 mmol) in dry toluene (10 ml) was stirred at room temperature for 2 h. The reaction mixture was neutralized by the addition of Et 3 N (300 ml) at the same temperature. The solvent was removed in vacuo, the residue was dissolved in CH 2 Cl 2 (100 ml), washed with water (100 mlϫ3). After drying over Na 2 SO 4 , the extract was concentrated to give cyclic ortho ester intermediate 17 as a colorless syrup. The crude was then dissolved in 80% aq. HOAc (10 ml) and stirred at room temperature for 1.5 h. Coevaporation with toluene yielded a colorless syrup, which was then subjected to Si gel column chromatography using 
To a solution of 18 (240 mg, 0.35 mmol) in dry pyridine (10 ml), BzCl (122 ml, 1.05 mmol) was added slowly at 0°C. After addition complete, the reaction mixture was warmed up to room temperature and stirred for overnight. Water (0.40 ml) was added slowly to quench the reaction and the solvent was removed in vacuo. The resulting residue was dissolved in CH 2 Cl 2 (50 ml), washed with water (50 mlϫ3), and then dried over Na 2 SO 4 to afford crude compound 19 as a white amorphous solid, which was then dissolved in dry CH 2 Cl 2 -MeOH (1 : 2, 15 ml). To the solution was added AcCl (300 ml) at 0°C, and the solution was allowed to warm to room temperature and stirred for 12 h when starting material was completely disappeared. Et 3 N (1.20 ml) was added to neutralize the acid. The solution was then concentrated and purified with a Si column chromatography using 
A suspension of 20 (90 mg, 0.12 mmol), trichloroacetimidate 8 (107 mg, 0.14 mmol), and 4 Å molecular sieves (300 mg) in dry CH 2 Cl 2 (10 ml) was treated with TMSOTf (2 ml, 0.1 eq) in the same manner as that described for compound 9. The product was purified by a Si gel column chromatography using the gradient solvent system (cHx-EtOAc, 3 . Cell Culture Assay The cytotoxicity assay was carried out according to the SRB assay described previously. 27) Three human cancer cell lines, A-549 (Lung cancer), SK-OV-3 (Ovarian cancer) and SK-MEL-2 (Skin cancer) were examined, and doxorubicin was used as the positive control (ED 50 : 0.02, 0.1, 0.04 mM, respectively). Growth inhibition of 50% (ED 50 ) of 3 calculated using the method described elsewhere. 28) Briefly, the cells were divided into 96-well plates and preincubated on the plates for 24 h. The compounds were added to the wells and incubated for 48 h. After incubation, the culture medium in each well was removed, and the cells were fixed with cold 10% trichloroacetic acid. Subsequently, a 0.4% SRB solution in 1% acetic acid was added to each well. The optical density was measured in a microtiter plate reader at 540 nm.
